Fractyl Health (GUTS) issued a press release on July 15, 2026, with one-year results from the REMAIN-1 Midpoint Cohort evaluating its Revita DMR System. The device is designed to help patients maintain weight loss after discontinuing GLP-1 receptor agonist therapies. The company also hosted a conference call to discuss the data.
View Full Filing (SEC EDGAR)Fractyl Health INC
-$216.9M
Net Activity
Institutions Holding
84
Popularity Rank
#4838
Avg Weight
0.06%
Total Value
$33.6M
Ownership Trend
84 institutions currently hold GUTS, with 31 net buyers and 58 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Majority Decreased
Based on recent trading activity
Net Selling Institutions
58
Net Buying Institutions
31
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$15.5M
Total Buy Value
$124.4M
Total Sell Value
31
Net Buyers
58
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
No Form 144 planned sale filings in the last 90 days
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
FAQ
Who are the top institutional investors holding FRACTYL HEALTH INC (GUTS)?
What is the overall institutional sentiment toward GUTS recently?
Which institutions have been selling or reducing their GUTS positions?
Are there any notable investors adding GUTS to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Amazon.com INC
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter